Zhang Tianli, Pan Yuexuan, Sawa Tomohiro, Akaike Takaaki, Matsunaga Tetsuro
Center for Integrated Control, Epidemiology and Molecular Pathophysiology of Infectious Diseases, Akita University, Akita, Japan.
Department of Redox Molecular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Front Immunol. 2025 Apr 16;16:1581385. doi: 10.3389/fimmu.2025.1581385. eCollection 2025.
Inflammation is one defense mechanism of the body that has multiple origins, ranging from physical agents to infectious agents including viruses and bacteria. The resolution of inflammation has emerged as a critical endogenous process that protects host tissues from prolonged or excessive inflammation, which can become chronic. Failure of the inflammation resolution is a key pathological mechanism that drives the progression of numerous inflammatory diseases. Owing to the various side effects of currently available drugs to control inflammation, novel therapeutic agents that can prevent or suppress inflammation are needed. Supersulfides are highly reactive and biologically potent molecules that function as antioxidants, redox regulators, and modulators of cell signaling. The catenation state of individual sulfur atoms endows supersulfides with unique biological activities. Great strides have recently been made in achieving a molecular understanding of these sulfur species, which participate in various physiological and pathological pathways. This review mainly focuses on the anti-inflammatory effects of supersulfides. The review starts with an overview of supersulfide biology and highlights the roles of supersulfides in both immune and inflammatory responses. The various donors used to generate supersulfides are assessed as research tools and potential therapeutic agents. Deeper understanding of the molecular and cellular bases of supersulfide-driven biology can help guide the development of innovative therapeutic strategies to prevent and treat diseases associated with various immune and inflammatory responses.
炎症是人体的一种防御机制,其起源多种多样,从物理因素到包括病毒和细菌在内的感染因子。炎症消退已成为一种关键的内源性过程,可保护宿主组织免受可能转为慢性的长期或过度炎症的影响。炎症消退失败是驱动众多炎症性疾病进展的关键病理机制。由于目前用于控制炎症的药物存在各种副作用,因此需要能够预防或抑制炎症的新型治疗药物。超硫化物是具有高反应性和生物活性的分子,可作为抗氧化剂、氧化还原调节剂和细胞信号传导调节剂发挥作用。单个硫原子的连接状态赋予超硫化物独特的生物活性。最近在对这些参与各种生理和病理途径的硫物种的分子理解方面取得了巨大进展。本综述主要关注超硫化物的抗炎作用。综述首先概述了超硫化物生物学,并强调了超硫化物在免疫和炎症反应中的作用。评估了用于生成超硫化物的各种供体作为研究工具和潜在治疗药物的情况。对超硫化物驱动的生物学的分子和细胞基础有更深入的了解,有助于指导开发创新的治疗策略,以预防和治疗与各种免疫和炎症反应相关的疾病。